Avivagen Inc.
VIVXF
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | - |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
October 2, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$469,679
Average shareholder expectationNext Earnings Call
Expected Date
December 30, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$751,899
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Avivagen Inc.
13 employees
CEO: G. F. Kym Anthony Avivagen Inc. is a life sciences firm primarily engaged in creating and distributing specialized feed supplements for livestock. These products are designed to bolster animals' immune function and contribute to their enhanced growth and ...